Sage Therapeutics (SAGE) PT Lowered to $49 at Morgan Stanley
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Morgan Stanley analyst Vikram Purohit lowered the price target on Sage Therapeutics (NASDAQ: SAGE) to $49.00 (from $50.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Gemini Space Station (GEMI) PT Lowered to $6 at Rosenblatt
- STAAR Surgical (STAA) PT Lowered to $28 at Stifel After Net-Positive Earnings Call
- Yesway Inc (YSWY) PT Raised to $32 at Guggenheim
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
